A full refund is available in exactly two situations: a medical provider determines you're not clinically eligible during the initial consultation, or a billing error occurred on Omzo's side
LIRA and SEMA gained approval from the Food and Drug Administration and the European Medicines Agency for weight loss in obese individuals or people who are overweight with BMI 27 kg/m 2 and have experienced at least one weight-associated comorbid condition (such as prediabetes, hypertension, dyslipidaemia, and OSA) combined with lifestyle modifications [63]
Furthermore, Semaglutides formulation allows for less frequent dosing, typically once weekly, compared to Liraglutide, which is usually taken daily
Rarely, it can lead to severe complications such as pancreatitis or thyroid tumors
Song G, Yang D, Wang Y, de Graaf C, Zhou Q, Jiang S, et al